APELLIS PHARMACEUTICALS

No, connecting with a site does not obligate you to participate, nor does it guarantee your eligibility to participate in the study. Participating in this or any clinical trial is completely voluntary. If you decide to participate in a research study, you are always free to withdraw at any time without any penalty or effect on your future medical care... PIONEER is a clinical research study evaluating the investigational medication, pegcetacoplan, in adolescents who have been diagnosed with PNH.

Also known as: Apellis Pharmaceuticals, Inc.

Primary location: Lake Oswego United States